LGR5 and ovarian carcinoma: In recent years, studies have revealed that Lgr5 is overexpressed in various types of tumors, including colorectal cancer, hepatocellular carcinoma, ovarian cancer, glioma, basal cell carcinoma and gastric carcinoma [18–20].